s
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
30-04-2024, 13:06
ZUG, Switzerland, April 30, 2024 /PRNewswire/ — Medison Pharma (“Medison”), a global pharma company focused on providing access to highly innovative therapies for patients in international markets, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today a further expansion of their existing partnership in Central & Eastern Europe and Israel, to also include selected […] L'articolo Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia proviene da La Ragione.
CONTINUA A LEGGERE
9
0
0
Guarda anche
La Ragione
01:43
Champions dolceamara per l’Atalanta, 0-0 contro l’Arsenal
La Ragione
Ieri, 23:43
G7 cultura, Giuli accoglie delegazioni a Napoli
La Ragione
Ieri, 22:43
La Russa “Non sono complottista, centrodestra non è accerchiato”
La Ragione
Ieri, 20:43
Sinner ambassador di Milano-Cortina, Malagò “Ha entusiasmo e umiltà”
La Ragione
Ieri, 20:38
Torna Striscia la notizia con la velina e il velino. Tutte le novità della 37esima edizione
La Ragione
Ieri, 20:04